DELIVERY DATE AI™ 

FDA DE NOVO GRANTED

A more accurate due date, when it matters most.
Some due dates are harder to know. Delivery Date AI™ helps clinicians find a clearer answer — from the ultrasound they're already using, without disrupting the visit. 
Designed for practices of any size, anywhere care happens.
Indicated for singleton pregnancies between 14 0/7 and 36 6/7 weeks gestation where a reliable estimated delivery date is unavailable.
Regulatory Status:

Brazil: Approved (ANVISA registration number: 82499100004)

Chile: Currently offered under local regulatory allowances.
Not yet subject to mandatory ISP registration

United States: FDA De Novo Granted

WHY DATING MATTERS
When due dates are uncertain, decisions are harder.
An accurate due date is the foundation of obstetric care. It shapes screening timing, growth assessments, intervention windows, and delivery planning.
One third
more likely to need NICU care when a due date was less certain
18.07% vs. 13.25% · p = 0.01 · N = 2,113 · JMIR Pediatrics & Parenting, Reis et al. 2020
35%
of US counties are maternity care deserts, home to 2.3M women of reproductive age
March of Dimes, 2024
24.5%
of US pregnancies did not begin prenatal care in the first trimester
CDC, 2024
Delivery Date AI™ was built for these moments. It brings consistent dating to clinicians anywhere care happens, even when standard methods fall short.
Backed by peer-reviewed clinical research
Delivery Date AI's underlying technology has been validated across more than 5,700 patients in a peer-reviewed study.
Journal of Maternal-Fetal & Neonatal Medicine.
Patel N, O'Brien J, Bunn R, et al. J Matern Fetal Neonatal Med. 2025;38(1):2532099.
View the publication
For expectant families
If your doctor has mentioned questions about your due date, you are not alone. Find answers to common questions about pregnancy dating and what to ask your care team.
For Parents and Families

Real stories. 
Real results.

What our patients and providers are saying.
"I was very surprised when I learned about this artificial intelligence. I don't fully understand it, but if it's good for my baby, I am deeply grateful for it."
Rubiangel Vilchez
Expectant Mother
"When I found out that the medical center had technology to help determine if my baby had a chance of being born prematurely, I immediately asked to try it. Having this technology in my ultrasounds makes me feel much safer and more at ease."
Camila Velásquez
First-time Mother
"I can give my testimony as the owner of Bebe Lab and a witness to the first patient attended with the app. As an institution, we feel confident using this technology, as it helps solve problems before they arise. It is simply a genius innovation that is saving lives."
Loreto Silva
Owner, BeBe Lab Medical Center
"I have had several ultrasounds using this system, and it has given me more confidence because I feel more supported throughout my journey."
Jhonimar Ortega
Expectant Mother

Available now

Request a clinical evaluation.

    Trusted partners

    Featured News & Media

    View all news and media
    The Science Behind the Mission: Robert Bunn on The Healthtech Podcast
    Apr 15, 2026

    The Science Behind the Mission: Robert Bunn on The Healthtech Podcast

    The Healthtech Podcast spoke with our founder Robert Bunn about what AI discovered in standard ultrasound images and what it means to bring predictive prenatal care to every woman on earth.

    Read More
    Our Founder Robert Bunn Shares the Story Behind Delivery Date AI™ with CBS News Colorado
    April 9, 2026

    Our Founder Robert Bunn Shares the Story Behind Delivery Date AI™ with CBS News Colorado

    CBS News Colorado sat down with our founder Robert Bunn to explore the personal story behind Delivery Date AI™ and what it means to bring earlier signal to clinicians caring for pregnant families.

    Read More
    Ultrasound AI Receives FDA De Novo Designation for AI-Powered Delivery Date Prediction
    March 3, 2026

    Ultrasound AI Receives FDA De Novo Designation for AI-Powered Delivery Date Prediction

    The U.S. Food and Drug Administration granted De Novo designation for Delivery Date AI™, marking a significant milestone for AI-powered delivery date prediction in prenatal care.

    Read More
    Robert Bunn Discusses Advancements in Prenatal Care using AI on PBS
    December, 6, 2025

    Robert Bunn Discusses Advancements in Prenatal Care using AI on PBS

    Robert Bunn, founder and president of Ultrasound AI on PBS News.

    Read More
    cross